BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 829492)

  • 1. Freeze-drying of brucella vaccine strain B 19.
    Valette L; Stellmann C; Précausta P; Desmettre P; Le Pemp M
    Dev Biol Stand; 1976 Oct; 36():313-22. PubMed ID: 829492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of temperature and degree of vacuum on the conservation of freeze-dried Brucella abortus strain 19 vaccine].
    García-Carrillo C
    Zentralbl Veterinarmed B; 1982 Feb; 29(1):57-66. PubMed ID: 6807032
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of five mediums for the stabilization of Brucella abortus strain 19 dessicated by lyophilization.
    Angus RD; Love EL; Pietz DE
    Dev Biol Stand; 1976 Oct; 36():307-12. PubMed ID: 829491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of Brucella abortus strain RB51 lyophilized and as liquid vaccine under different storage conditions.
    Capsel RL; Olsen SC; Cheville NF; Thoen CO
    Biologicals; 2000 Dec; 28(4):209-15. PubMed ID: 11237356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trials of the use of live vaccines against brucellosis and listeriosis in farm animals].
    Titov VV
    Arch Exp Veterinarmed; 1980; 34(1):115-8. PubMed ID: 6774688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the stability of Brucella abortus strain 19 reduced dosage lyophilized vaccines produced by different methods.
    Angus RD
    Dev Biol Stand; 1984; 56():659-78. PubMed ID: 6436119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of freeze-drying on the potency and stability of live varicella virus vaccine.
    Bennett PS; Maigetter RZ; Olson MG; Provost PJ; Scattergood EM; Schofield TL
    Dev Biol Stand; 1992; 74():215-21. PubMed ID: 1317307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures.
    Sparkes JD; Fenje P
    Bull World Health Organ; 1972; 46(6):729-34. PubMed ID: 4538534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle.
    Palmer MV; Olsen SC; Cheville NF
    Am J Vet Res; 1997 May; 58(5):472-7. PubMed ID: 9140553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the preparation of a lyophilized Brucella abortus live vaccine ("Buck 19"). 1. On the effect of various stabilizators on the number of live cells].
    Boden W
    Arch Exp Veterinarmed; 1965 Apr; 19(1):281-7. PubMed ID: 4953584
    [No Abstract]   [Full Text] [Related]  

  • 14. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence.
    Lord VR; Schurig GG; Cherwonogrodzky JW; Marcano MJ; Melendez GE
    Am J Vet Res; 1998 Aug; 59(8):1016-20. PubMed ID: 9706206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.
    Wallach JC; Ferrero MC; Victoria Delpino M; Fossati CA; Baldi PC
    Clin Microbiol Infect; 2008 Aug; 14(8):805-7. PubMed ID: 18727806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moisture measurement: a new method for monitoring freeze-drying cycles.
    Bardat A; Biguet J; Chatenet E; Courteille F
    J Parenter Sci Technol; 1993; 47(6):293-9. PubMed ID: 8120734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moisture transfer from stopper to product and resulting stability implications.
    Pikal MJ; Shah S
    Dev Biol Stand; 1992; 74():165-77; discussion 177-9. PubMed ID: 1592166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venezuelan field trials of vaccines against brucellosis in swine.
    Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
    Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
    Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
    Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.